Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
Authors
Keywords
-
Journal
Cancers
Volume 2, Issue 2, Pages 913-954
Publisher
MDPI AG
Online
2010-05-26
DOI
10.3390/cancers2020913
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
- (2010) Martin Pölcher et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Serological and immunohistochemical HER-2/neu statuses do not correlate and lack prognostic value for ovarian cancer patients
- (2010) M. HOOPMANN et al. EUROPEAN JOURNAL OF CANCER CARE
- Prognostic Value of Human Epidermal Growth Factor Receptor 2 (Her-2)/neu in Patients With Advanced Ovarian Cancer Treated With Platinum/Paclitaxel as First-Line Chemotherapy
- (2010) Jacobus Pfisterer et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Relationship of Platinum Resistance and ERCC1 Protein Expression in Epithelial Ovarian Cancer
- (2010) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters
- (2009) CHIH-KUNG LIN et al. APMIS
- Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
- (2009) I. Kryczek et al. BLOOD
- Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
- (2009) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes
- (2009) M Stumpf et al. BRITISH JOURNAL OF CANCER
- Intraepithelial T cells and tumor proliferation
- (2009) Sarah F. Adams et al. CANCER
- Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
- (2009) Min Fei et al. CANCER INVESTIGATION
- FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
- (2009) I. Kryczek et al. CANCER RESEARCH
- Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells
- (2009) N. Eckstein et al. CANCER RESEARCH
- Current status of anti-angiogenic agents in the treatment of ovarian carcinoma
- (2009) Alfonso Sánchez-Muñoz et al. Clinical & Translational Oncology
- New therapeutic agents in ovarian cancer
- (2009) Fiona Collinson et al. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
- c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome
- (2009) Marina Bagnoli et al. ENDOCRINE-RELATED CANCER
- Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
- (2009) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma
- (2009) Hyo Sup Shim et al. HUMAN PATHOLOGY
- Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
- (2009) Lilach Kleinberg et al. HUMAN PATHOLOGY
- Ovarian carcinoma pathology and genetics: recent advances
- (2009) C. Blake Gilks et al. HUMAN PATHOLOGY
- Epidermal Growth Factor Receptor Expression in Serous Ovarian Carcinoma: An Immunohistochemical Study With Galectin-3 and Cyclin D1 and Outcome
- (2009) Hermann Brustmann INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Expression of DNA Damage Checkpoint Protein Hus1 in Epithelial Ovarian Tumors Correlates With Prognostic Markers
- (2009) Javier de la Torre et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma
- (2009) Mari Bunkholt Elstrand et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer
- (2009) Timothy J. Duncan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection
- (2009) K Engels et al. JOURNAL OF CLINICAL PATHOLOGY
- Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis
- (2009) Areeg Faggad et al. MODERN PATHOLOGY
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
- (2009) Henry T. Lynch et al. Molecular Oncology
- Mutation ofFOXL2in Granulosa-Cell Tumors of the Ovary
- (2009) Sohrab P. Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cell Density and Location Can Influence the Prognosis of Ovarian Cancer
- (2009) Ahmad Al-Attar et al. PATHOLOGY & ONCOLOGY RESEARCH
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary
- (2008) Martin Köbel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
- (2008) Joshua Z Press et al. BMC CANCER
- Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients
- (2008) G Ferrandina et al. BRITISH JOURNAL OF CANCER
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
- (2008) S M Alam et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma
- (2008) Adelaida García-Velasco et al. Clinical & Translational Oncology
- Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
- (2008) T. J. Duncan et al. CLINICAL CANCER RESEARCH
- Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
- (2008) Angiolo Gadducci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- TP53, BCL-2 and BAX analysis in 199 ovarian cancer patients treated with taxane-platinum regimens
- (2008) Izabela Ziółkowska-Seta et al. GYNECOLOGIC ONCOLOGY
- Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer
- (2008) Franco Muggia GYNECOLOGIC ONCOLOGY
- The impact of T-cell immunity on ovarian cancer outcomes
- (2008) Brad H. Nelson IMMUNOLOGICAL REVIEWS
- Consortium analysis of 7 candidate SNPs for ovarian cancer
- (2008) Susan J. Ramus et al. INTERNATIONAL JOURNAL OF CANCER
- Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer
- (2008) Alain G. Zeimet et al. INTERNATIONAL JOURNAL OF CANCER
- The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer
- (2008) Johanne Weberpals et al. INTERNATIONAL JOURNAL OF CANCER
- Protein expression levels of excision repair cross-complementation group 1 and xeroderma pigmentosum D correlate with response to platinum-based chemotherapy in the patients with advanced epithelial ovarian cancer
- (2008) K. LIN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Alteration of cell-cycle regulation in epithelial ovarian cancer
- (2008) E.J. NAM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- A Decade of Tissue Microarrays: Progress in the Discovery and Validation of Cancer Biomarkers
- (2008) Robert L. Camp et al. JOURNAL OF CLINICAL ONCOLOGY
- Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
- (2008) D. de Jong et al. JOURNAL OF CLINICAL PATHOLOGY
- Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design
- (2008) Margaret S. Pepe et al. JNCI-Journal of the National Cancer Institute
- Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas
- (2008) Bernard Têtu et al. MODERN PATHOLOGY
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer
- (2008) Weiya Xia et al. MOLECULAR CARCINOGENESIS
- Increased staining for phosphorylated AKT and nuclear factor-κB p65 and their relationship with prognosis in epithelial ovarian cancer
- (2008) Rui-Xia Guo et al. PATHOLOGY INTERNATIONAL
- The prognostic significance of COX-2 and survivin expression in ovarian cancer
- (2008) Pauline Athanassiadou et al. PATHOLOGY RESEARCH AND PRACTICE
- Human papilloma virus (HPV) status, p16INK4a, and p53 overexpression in epithelial malignant and borderline ovarian neoplasms
- (2008) Giovanna Giordano et al. PATHOLOGY RESEARCH AND PRACTICE
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer
- (2007) Sylvia Stadlmann et al. GYNECOLOGIC ONCOLOGY
- Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
- (2007) Aristotelis Bamias et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
- (2007) Markéta Tomšová et al. GYNECOLOGIC ONCOLOGY
- Expression of hypoxia-inducible factor 1α gene affects the outcome in patients with ovarian cancer
- (2007) R. SHIMOGAI et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Is It Time to Stratify for BRCA Mutation Status in Therapeutic Trials in Ovarian Cancer?
- (2007) Noah D. Kauff JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma
- (2006) Bo Sung Yoon et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started